8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer)
Published . Updated .
Filed: 2026-10-05 AccNo: 0001437749-26-032042 Size: 210 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Directly affected
- NRXP NRX Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-05 AccNo: 0001437749-26-032042 Size: 210 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
NRX Pharmaceuticals (NRXP) since “8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer),” compared with the market
Since the first closing price after “8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer),” NRX Pharmaceuticals (NRXP) is -9.62%. The S&P 500 fund (SPY) is -1.36% over the same days, a -8.26% difference versus the market.
Who gains and who loses around NRX Pharmaceuticals (NRXP)
Companies mentioned with this story
- NRXP NRX Pharmaceuticals
NRX Pharmaceuticals (NRXP) is linked, with no stored direction, high confidence in the 6 Oct 2026 story “8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> NRXP
- XPH State Street Spdr S&P Pharmaceuticals Etf
State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence in the 6 Oct 2026 story “8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer).” Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer)” reaches NRX Pharmaceuticals (NRXP)
“8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer)” (6 Oct 2026) reaches NRX Pharmaceuticals (NRXP) through this story.
The link for NRX Pharmaceuticals (NRXP) is this: SEC 8-K filing -> direct issuer disclosure -> NRXP
Also listed, State Street Spdr S&P Pharmaceuticals Etf (XPH): GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for NRX Pharmaceuticals (NRXP)
NRXP traded between 2.49 and 2.98 across 10 sessions. The latest close on file is 2.63. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
How strong the case is around NRX Pharmaceuticals (NRXP)
21 out of 100
“8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer)” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.